Skip to content

News / Analytics / Reviews

Stock Market Analysis
Corporate News
Financial News

Earnings Snapshot: TG Therapeutics beats Q4 estimates, targets FY25 global revenue of ~$540M

Posted on March 3, 2025 by wpadmin

*Other Operating Data Consensus Source: Bloomberg

Posted in Corporate NewsTagged TGTX

Post navigation

Previous: Palantir could see more deals, IT dollars from Washington: Wedbush

Next: Intel rises after report of Nvidia, Broadcom testing chips on manufacturing process – report

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Comment *

Name *

Email *

Website

Save my name, email, and website in this browser for the next time I comment.

Δ

Search

Recent Posts

Texas Stock Exchange boosts capital raise to $270M as Goldman, BofA lead $20M round
Lucid launches ‘Lucid Recharged’ program to sell certified, pre-owned EVs
Starbucks added as a new long idea at Hedgeye
Arm, Texas Instruments and Entegris receive downgrades by Goldman Sachs
ServiceNow, Adobe downgraded at KeyBanc; Akamai, Fastly, Asana, ZoomInfo upped

Recent Comments

Tom Ford on Affirm: A Genuine Innovation In Finance
Tim Donohue on Tilray Brands Q3 Earnings: Another Disappointing Quarter
PAUL URSUL on Lucid Troubles Keep Building
Warpaint on AT&T: A Classic Value Trap
Tyrion Lannister on Microsoft: AI, A Product Development Boon

Archives

Categories

Corporate News
Financial News
Stock Market Analysis

Powered By WordPress | Newsmagify